The Impact of COVID-19 is included in Pulmonary Drug Delivery Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Pulmonary Drug Delivery Trends and Forecast
The future of the global pulmonary drug delivery market looks promising with opportunities in the hospitals & clinic and home care markets. The global pulmonary drug delivery market is expected to reach an estimated $68.1 billion by 2030 with a CAGR of 2.5% from 2024 to 2030. The major drivers for this market are rising prevalence of respiratory diseases, growing awareness towards the benefits of pulmonary drug delivery, and increasing demand for home-based healthcare services.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Pulmonary Drug Delivery by Segment
The study includes a forecast for the global pulmonary drug delivery by application, end use, distribution channel, and region.
Pulmonary Drug Delivery Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Asthma
• Chronic Obstructive Pulmonary Disease
• Allergic Rhinitis
• Cystic Fibrosis
• Others
Pulmonary Drug Delivery Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals & Clinics
• Home Care
Pulmonary Drug Delivery Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
• Hospital Pharmacies
• Retail Pharmacies
• E-Commerce
Pulmonary Drug Delivery Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Pulmonary Drug Delivery Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pulmonary drug delivery companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pulmonary drug delivery companies profiled in this report include-
• Glaxosmithkline
• 3M Company
• Koninklijke Philips
• Astrazeneca
• Boehringer Ingelheim
Pulmonary Drug Delivery Market Insights
Lucintel forecasts that chronic obstructive pulmonary disease (COPD) will remain the largest segment over the forecast period due to increasing prevalence of respiratory diseases and favorable reimbursement policies towards the treatment of chronic obstructive pulmonary disease.
Within this market, hospitals & clinics will remain the larger segment due to growing number of hospital pharmacies across the globe.
North America will remain the largest region due to advanced healthcare system, which provides patients with access to the latest pulmonary drug delivery devices and treatments.
Features of the Global Pulmonary Drug Delivery Market
Market Size Estimates: Pulmonary drug delivery market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Pulmonary drug delivery market size by application, end use, distribution channel, and region in terms of value ($B).
Regional Analysis: Pulmonary drug delivery market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different applications, end uses, distribution channels, and regions for the pulmonary drug delivery market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pulmonary drug delivery market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the pulmonary drug delivery market size?
Answer: The global pulmonary drug delivery market is expected to reach an estimated $68.1 billion by 2030.
Q.2 What is the growth forecast for pulmonary drug delivery market?
Answer: The global pulmonary drug delivery market is expected to grow with a CAGR of 2.5% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the pulmonary drug delivery market?
Answer: The major drivers for this market are rising prevalence of respiratory diseases, growing awareness towards the benefits of pulmonary drug delivery, and increasing demand for home-based healthcare services.
Q4. What are the major segments for pulmonary drug delivery market?
Answer: The future of the pulmonary drug delivery market looks promising with opportunities in the hospitals & clinic and home care markets.
Q5. Who are the key pulmonary drug delivery market companies?
Answer: Some of the key pulmonary drug delivery companies are as follows:
• Glaxosmithkline
• 3M Company
• Koninklijke Philips
• Astrazeneca
• Boehringer Ingelheim
Q6. Which pulmonary drug delivery market segment will be the largest in future?
Answer: Lucintel forecasts that chronic obstructive pulmonary disease (COPD) will remain the largest segment over the forecast period due to increasing prevalence of respiratory diseases and favorable reimbursement policies towards the treatment of chronic obstructive pulmonary disease.
Q7. In pulmonary drug delivery market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to advanced healthcare system, which provides patients with access to the latest pulmonary drug delivery devices and treatments.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the pulmonary drug delivery market by application (asthma, chronic obstructive pulmonary disease, allergic rhinitis, cystic fibrosis, and others), end use (hospitals & clinics and home care), distribution channel (hospital pharmacies, retail pharmacies, and e-commerce), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Pulmonary Drug Delivery Market, Pulmonary Drug Delivery Market Size, Pulmonary Drug Delivery Market Growth, Pulmonary Drug Delivery Market Analysis, Pulmonary Drug Delivery Market Report, Pulmonary Drug Delivery Market Share, Pulmonary Drug Delivery Market Trends, Pulmonary Drug Delivery Market Forecast, Pulmonary Drug Delivery Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Pulmonary Drug Delivery Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Pulmonary Drug Delivery Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Pulmonary Drug Delivery Market by Application
3.3.1: Asthma
3.3.2: Chronic Obstructive Pulmonary Disease
3.3.3: Allergic Rhinitis
3.3.4: Cystic Fibrosis
3.3.5: Others
3.4: Global Pulmonary Drug Delivery Market by End Use
3.4.1: Hospitals & Clinics
3.4.2: Home Care
3.5: Global Pulmonary Drug Delivery Market by Distribution Channel
3.5.1: Hospital Pharmacies
3.5.2: Retail Pharmacies
3.5.3: E-commerce
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Pulmonary Drug Delivery Market by Region
4.2: North American Pulmonary Drug Delivery Market
4.2.2: North American Pulmonary Drug Delivery Market by End Use: Hospitals & Clinics and Home Care
4.3: European Pulmonary Drug Delivery Market
4.3.1: European Pulmonary Drug Delivery Market by Application: Asthma, Chronic Obstructive Pulmonary Disease, Allergic Rhinitis, Cystic Fibrosis, and Others
4.3.2: European Pulmonary Drug Delivery Market by End Use: Hospitals & Clinics and Home Care
4.4: APAC Pulmonary Drug Delivery Market
4.4.1: APAC Pulmonary Drug Delivery Market by Application: Asthma, Chronic Obstructive Pulmonary Disease, Allergic Rhinitis, Cystic Fibrosis, and Others
4.4.2: APAC Pulmonary Drug Delivery Market by End Use: Hospitals & Clinics and Home Care
4.5: ROW Pulmonary Drug Delivery Market
4.5.1: ROW Pulmonary Drug Delivery Market by Application: Asthma, Chronic Obstructive Pulmonary Disease, Allergic Rhinitis, Cystic Fibrosis, and Others
4.5.2: ROW Pulmonary Drug Delivery Market by End Use: Hospitals & Clinics and Home Care
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Pulmonary Drug Delivery Market by Application
6.1.2: Growth Opportunities for the Global Pulmonary Drug Delivery Market by End Use
6.1.3: Growth Opportunities for the Global Pulmonary Drug Delivery Market by Distribution Channel
6.1.4: Growth Opportunities for the Global Pulmonary Drug Delivery Market by Region
6.2: Emerging Trends in the Global Pulmonary Drug Delivery Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Pulmonary Drug Delivery Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pulmonary Drug Delivery Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: GlaxoSmithKline
7.2: 3M Company
7.3: Koninklijke Philips
7.4: AstraZeneca
7.5: Boehringer Ingelheim
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Pulmonary Drug Delivery Market Report.